The five-year survival rate for patients with mid-stage colon cancer, after treatment, is about 60% to 70%, which can vary.
Colon cancer is a common malignant tumor caused by gene mutation, heredity and other factors. If mid-stage patients have the chance of surgical resection, neoadjuvant chemotherapy can usually be used first to reduce the size of the lesion and increase the rate of surgical resection. After surgery, radiotherapy, targeted therapy and other adjuvant treatments can be performed according to the condition.
After active treatment, mid-stage colon cancer patients can get a five-year survival rate of 60%~70%. If the patients are in good physical condition and tolerate the treatment well, the clinical cure rate can be increased to a certain extent. After surgery, patients should pay attention to regular checkups and good living habits as prescribed by doctors.